CN Patent

CN108148106A — 一类水溶性别孕烯醇酮衍生物及其用途

Assigned to Jiangsu Nhwa Luo Kang Pharmaceutical Research & Development Co Ltd · Expires 2018-06-12 · 8y expired

What this patent protects

本发明涉及医药领域，具体涉及一类水溶性别孕烯醇酮衍生物、包含其的药物组合物及其用于预防或治疗中枢神经系统病症、用于镇静催眠、用于抗肿瘤、用于制备免疫抑制剂或者用于预防或治疗器官移植后的排斥反应的用途。

USPTO Abstract

本发明涉及医药领域，具体涉及一类水溶性别孕烯醇酮衍生物、包含其的药物组合物及其用于预防或治疗中枢神经系统病症、用于镇静催眠、用于抗肿瘤、用于制备免疫抑制剂或者用于预防或治疗器官移植后的排斥反应的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN108148106A
Jurisdiction
CN
Classification
—
Expires
2018-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Nhwa Luo Kang Pharmaceutical Research & Development Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.